OBIO vs WY · rev $198.0K vs P/E 43, rev $3.59B
Orchestra BioMed Holdings Inc. (OBIO) versus Weyerhaeuser Company (WY) — a side-by-side from cached financials, not a winner call.
Orchestra BioMed Holdings Inc. (OBIO) is a biotechnology company listed on NASDAQ.
Weyerhaeuser Company (WY) is a reit - specialty company listed on NYSE.
Latest reported OBIO revenue for 2026-06-30 was $198.0K. Net income was -$44.4M. Revenue was up 80.0% from 2026-03-31 to 2026-06-30. OBIO currently screens at market cap $231.7M.
Latest reported WY revenue for 2026-06-30 was $3.59B. Net income was $318.0M. WY currently screens at market cap $17.54B and trailing P/E 43.4.
OBIO currently screens at market cap $231.7M. WY currently screens at market cap $17.54B and trailing P/E 43.4.
Not investment advice. Open the OBIO and WY stock pages for the full models.
Not investment advice.